VITAL MEDICINES NOT AVAILABLE: NATIONAL AND INTERNATIONAL REGULATION ANALYSIS, UPDATE PROPOSAL OF NATIONAL LIST
A comparative revision was carried out on the national and international policies and regulations about access of orphan and/or vital drugs.. An analysis of: orphan drugs´ list from USA, European Union and all applications for importation of not available drugs submitted by the Drug Regulatory Autho...
Enregistré dans:
| Auteurs principaux: | , , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Universidad de Antioquia
2009
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/3a565dfc710f46d5a42c3ae53e1fd181 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
| Résumé: | A comparative revision was carried out on the national and international policies and regulations about
access of orphan and/or vital drugs.. An analysis of: orphan drugs´ list from USA, European Union
and all applications for importation of not available drugs submitted by the Drug Regulatory Authority
(INVIMA) until 2006; an informal consultation with health care providers, insurance companies and
distributors of vital medicines, were included, in order to improve the actual vital drugs list within the
frame of public health programs. The analysis included all drugs that have been protected by Decree
2085 from 2002, as well as the imported drugs by the Ministry of Social Welfare under the public
health program. 26 of 107 proposed drugs match the lists of orphan drugs from the countries analyzed
and 12 are protected with exclusivity by decree 2085 from 2002.
|
|---|